Internal Medicine, Hematology & Oncology · Austin, TX
NPI
1215197314
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6204 Balcones Dr
Austin, TX, 78731
Phone (512) 427-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
170,848 services
Medicare patients, 2024
705
Average age 74
Drug cost, 2024
$7.4M
2,506 prescriptions
Company payments, 2025
$1,747
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey T Yorio was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 20,390 times for 15 patients. In total Jeffrey T Yorio billed 170,848 services in 208 codes, and Medicare paid $3.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 20,390 | 15 | $2.34 | $48K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 15,300 | 45 | $0.11 | $1,712 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,300 | 26 | $44.55 | $637K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 9,000 | 79 | $0.10 | $896 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 9,000 | 11 | $0.06 | $499 |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,374 | 21 | $0.08 | $586 |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,900 | 15 | $0.17 | $1,172 |
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 14 | $17.25 | $48K |
| Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | Office | 2,470 | 12 | $50.21 | $124K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 1,800 | 12 | $37.28 | $67K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,759 | 70 | $0.09 | $158 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,310 | 56 | $0.73 | $958 |
| 85025 Blood Count | Office | 1,250 | 310 | $7.58 | $9,474 |
| 36415 Venipuncture Blood Collection | Office | 1,145 | 298 | $8.65 | $9,904 |
| 80053 Clinical Chemistry | Office | 1,109 | 264 | $10.31 | $11K |
By year: 2022 $2.3M for 169,040 services; 2023 $2.9M for 175,490 services; 2024 $3.0M for 170,848 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,250 | 310 | $7.58 | $9,474 |
| 36415 Venipuncture Blood Collection | 1,145 | 298 | $8.65 | $9,904 |
| 80053 Clinical Chemistry | 1,109 | 264 | $10.31 | $11K |
| 83735 Clinical Chemistry | 518 | 93 | $6.57 | $3,403 |
| 82784 Immunoassay | 225 | 44 | $9.11 | $2,051 |
| 85055 Blood Count | 161 | 38 | $35.03 | $5,640 |
| 83521 Immunoassay | 150 | 36 | $16.93 | $2,539 |
| 85007 Blood Count | 130 | 33 | $3.72 | $484 |
| 85027 Blood Count | 130 | 33 | $6.34 | $824 |
| 84443 Clinical Chemistry | 94 | 29 | $16.32 | $1,534 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey T Yorio prescribed most often to Medicare patients was Eliquis (Apixaban), with 156 prescriptions and refills. In total Jeffrey T Yorio wrote 2,506 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 156 | 242 | 28 | $134K |
| Potassium Chloride Generic | 124 | 150 | 32 | $1,896 |
| Levothyroxine Sodium Generic | 124 | 231 | 30 | $1,267 |
| Gabapentin Generic | 99 | 111 | 28 | $1,155 |
| Prednisone Generic | 87 | 122 | 34 | $390 |
| Revlimid Lenalidomide | 83 | 83 | 11 | $1.4M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 75 | 75 | 26 | $1,523 |
| Dexamethasone Generic | 72 | 80 | 36 | $1,320 |
| Xarelto Rivaroxaban | 69 | 147 | 15 | $79K |
| Ondansetron Odt Ondansetron | 61 | 61 | 35 | $1,047 |
| Acyclovir Generic | 58 | 90 | 12 | $730 |
| Pantoprazole Sodium Generic | 50 | 87 | 13 | $425 |
| Hydroxyurea Generic | 50 | 108 | 11 | $1,419 |
| Anastrozole Generic | 46 | 113 | 14 | $841 |
| Letrozole Generic | 44 | 91 | Under 11 | $509 |
Brand drugs: - claims; generic drugs: 1,772 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey T Yorio $1,747 ($477 in general payments such as food, travel and fees and $1,270 for research) from 17 companies. The largest payer was Pfizer Inc. with $1,403.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.